Publication | Closed Access

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

VaccinationVaccine SafetyVaccine DevelopmentVaccine EfficacySierra LeoneInfection ControlMedicineEpidemiologyHealthy Adults